Safety and Efficacy Study of Guaifenesin and Pseudoephedrine for Symptomatic Therapy to Treat Acute RTI
Clinical trial NCT01202279 · COMPLETED
Trial details
- NCT number
- NCT01202279
- Sponsor
- Reckitt Benckiser Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2009-10-01
- Primary completion
- 2010-04-01
- Enrollment
- 1179
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.